Hostname: page-component-745bb68f8f-f46jp Total loading time: 0 Render date: 2025-02-06T03:04:22.819Z Has data issue: false hasContentIssue false
  • English
  • Français

A Controlled Trial of Thiopropazate Dihydrochloride (Dartalan), Chlorpromazine and Occupational Therapy in Chronic Schizophrenics

Published online by Cambridge University Press:  08 February 2018

Max Hamilton ,
A. L. G. Smith ,
H. E. Lapidus  and
E. P. Cadogan
Max Hamilton
Affiliation:
Department of Psychiatry, Leeds University
A. L. G. Smith
Affiliation:
Storthes Hall Hospital, Huddersfield
H. E. Lapidus
Affiliation:
Storthes Hall Hospital, Huddersfield
E. P. Cadogan
Affiliation:
Storthes Hall Hospital, Huddersfield
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Since the introduction of chlorpromazine for the treatment of mental illnesses a number of other tranquillizing drugs, belonging to the phenothiazine group, have come into use. Experience has shown that the first of a new kind of drug is not necessarily the best and it is important that “variations on a theme” should be properly tested.

Type
Original Articles
Information
Journal of Mental Science , Volume 106 , Issue 442 , January 1960 , pp. 40 - 55
Copyright
Copyright © Royal College of Psychiatrists, 1960 

References

Bickford, J. A. R., “Chlorpromazine”, Brit. med. J., 1955, i, 1155.CrossRefGoogle Scholar
Edisen, C. B., and Samuels, A. S., “A clinical evaluation of Dartal chemotherapy for emotional disorders”, A.M.A. Arch. Neurol. and Psychiat., 1958, 80, 481.Google Scholar
Elkes, J., and Elkes, C., “Effects of chlorpromazine on the behaviour of chronically overactive psychotic patients”, Brit. med. J., 1954, ii, 560.CrossRefGoogle Scholar
Fleming, B. G., and Currie, J. D. C., “Investigation of a new compound, B.W.203, and of chlorpromazine in the treatment of psychosis”, J. Ment. Sci., 1958, 104, 749.CrossRefGoogle Scholar
Grygier, P., and Waters, M. A., “Chlorpromazine used with an intensive occupational therapy programme. A controlled study”, A.M.A. Arch. Neurol. and Psychiat., 1958, 79, 697.Google Scholar
Hall, R. A., and Dunlap, D. J., “A study of chlorpromazine: methodology and results with chronic semi-disturbed schizophrenics.” J. Nerv. Ment. Dis., 1955, 122, 301.CrossRefGoogle Scholar
Little, J. C., “A double-blind controlled comparison of the effects of chlorpromazine, barbiturate and a placebo in 142 chronic psychotic in-patients”, J. Ment. Sci., 1958, 104, 334.CrossRefGoogle Scholar
Lorr, M., “Multidimensional scale for rating psychiatric patients”, Hospital Form. Vet. Admin. tech. Bull., TB 10–507, Nov., 1953.Google Scholar
Merry, J., “An experiment in a chronic psychotic ward”, Brit. J. med. Psychol., 1956, 29, 287.CrossRefGoogle Scholar
Mitchell, P. H., “Chlorpromazine in the treatment of the chronic disturbed schizophrenic patient”, J. Ment. Sci., 1956, 102, 151.CrossRefGoogle Scholar
Robin, A. A., “The stabilizing effect of occupational therapy on chronic psychotics with a tendency to aggressive forms of behaviour”, J. Ment. Sci., 1957, 103, 597.CrossRefGoogle Scholar
Seager, C. P., “Chlorpromazine in treatment of elderly psychotic women”, Brit. med. J., 1955, i, 882.CrossRefGoogle Scholar
Vaughan, V. F., and Leiberman, D. M. “Chlorpromazine in psychiatry”, Lancet, 1955, i, 1083.CrossRefGoogle Scholar
Walsh, G. P., Walton, D., and Black, D. A., “The relative efficacy of ‘Vespral’ and chlorpromazine in the treatment of a group of chronic schizophrenic patients”, J. Ment. Sci. 1959, 105, 199.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.